The number of CLL patients diagnosed in China has been on a dramatic rise. One abstract at the recent iwCLL 2017 conference in New York asked: Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China? raising questions about the traditional belief of a low incidence of CLL in Asians.
CLL is classified as both a type of leukemia (cancer of the blood) and lymphoma (cancer of the lymphatic system) because the cancer is found in the blood and the cancer originates in cells that are part of lymphatic system. (re-use)
Research presented at ASCO 2017 found that just like older CLL patients, those with CLL younger than 55 years old are at higher risk for many secondary solid cancers mandating the need for conscientious screening. For full details see: http://abstracts.asco.org/199/AbstView_199_194206.html
Originally published in The CLL Tribune Q2 2017.